In the case of MAGL, one study found that the MAGL inhibitor URB602 reduced the growth of colon carcinoma xenografts, which was associated with reduced VEGF and fibroblast growth factor (FGF)-2 expression [154]. This evidence concerns the gene MGLL and colon carcinoma.